StockCIK 1232524
Jazz Pharmaceuticals plc (JAZZ): Insider Trades and Fund Holdings
In the past 12 months, Jazz Pharmaceuticals plc insiders reported 0 open-market purchases worth $0 and 6 sales worth $23.3M; 6 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$23.3MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 7, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 7 | Renee D. GalaCEO | ▼ SELL10b5-1 | $473K |
| Oct 5 | Bruce C. CozaddDirector | ▼ SELL10b5-1 | $1.38M |
| Sep 14 | Neena M. PatilGeneral Counsel | ▼ SELL10b5-1 | $289K |
| Sep 10 | Renee D. GalaCEO | ▼ SELL10b5-1 | $486K |
| Sep 2 | Bruce C. CozaddDirector | ▼ SELL10b5-1 | $1.50M |
| Aug 31 | Robert IannoneEVP | ▼ SELL10b5-1 | $19.2M |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Renee D. Gala | CEO | 0 | $0 | 2 | $959K |
| Bruce C. Cozadd | Director | 0 | $0 | 2 | $2.88M |
| Neena M. Patil | General Counsel | 0 | $0 | 1 | $289K |
| Robert Iannone | EVP | 0 | $0 | 1 | $19.2M |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report JAZZ
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 562,073 | $135.4M | ▼ −31.4% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →